Free shipping on all orders over $ 500

Brimonidine (UK 14304)

Cat. No. M8833
Brimonidine (UK 14304) Structure
Synonym:

Brimonidine; AGN190342; UK14304

Size Price Availability Quantity
5mg USD 60  USD60 In stock
10mg USD 100  USD100 In stock
50mg USD 400  USD400 In stock
100mg USD 700  USD700 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Brimonidine (UK 14304) is a full alpha2 adrenergic receptor agonist that can be used in studies related to open-angle glaucoma or hypermetropia.

Chemical Information
Molecular Weight 292.13
Formula C11H10BrN5
CAS Number 59803-98-4
Solubility (25°C) DMSO ≥ 30 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] M Salleras, et al. Spanish Consensus Document on the Treatment Algorithm for Rosacea

[2] Daniel J Oh, et al. Brimonidine tartrate for the treatment of glaucoma

[3] Danit Maor, et al. Rosacea

[4] Heather Francis, et al. The alpha2-adrenergic receptor agonist UK 14,304 inhibits secretin-stimulated ductal secretion by downregulation of the cAMP system in bile duct-ligated rats

[5] D Cambridge. UK-14,304, a potent and selective alpha2-agonist for the characterisation of alpha-adrenoceptor subtypes

Related Adrenergic Receptor Products
CRN04894

CRN04894 is an orally nonpeptide, potent and selective antagonist for adrenocorticotropic hormone (ACTH) acting at the melanocortin 2 receptor (MC2R). CRN04894 blocks the action of ACTH at MC2R, providing a potential novel treatment for the diseases of ACTH excess such as Cushing’s disease, congenital adrenal hyperplasia, and ectopic ACTH-secreting tumors.

(Des-His6)-ACTH (1-24) (human, bovine, rat)

(Des-His6)-ACTH (1-24) (human, bovine, rat) is an analogue of Adrenocorticotropic hormone (ACTH).

ACTH (1-14)

ACTH (1-14) is a fragment of adrenocorticotrophin, which regulates cortisol and androgen production.

Mibenratide

Mibenratide, a small cyclic peptide, is an adrenergic β1 receptor antagonist.

Conopeptide rho-TIA

Conopeptide rho-TIA is a peptide derived from the venom contained in the predatory sea snail Conus tulipa, has highly selective and noncompetitive inhibitor at human α1B-Adrenergic Receptor.

  Catalog
Abmole Inhibitor Catalog




Keywords: Brimonidine (UK 14304), Brimonidine; AGN190342; UK14304 supplier, Adrenergic Receptor, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.